Endonovo Therapeutics, Inc. (ENDV)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Mar 4, 2026, 4:00 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Biomedical Research and Development	135.36K	73.11K	165.80K	310.16K	83.26K
Biomedical Research and Development Growth	85.15%	-55.91%	-46.55%	272.51%	-
Total	135.36K	73.11K	165.80K	310.16K	83.26K
Total Growth	85.15%	-55.91%	-46.55%	272.51%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
United States	135.36K	73.11K	165.80K	310.16K	83.26K
United States Growth	85.15%	-55.91%	-46.55%	272.51%	-
Total	135.36K	73.11K	165.80K	310.16K	83.26K
Total Growth	85.15%	-55.91%	-46.55%	272.51%	-

Source: S&P Global Market Intelligence.